Structures by: Hutchins K. M.
Total: 140
Co-crystal of mefenamic acid and 4,4'-azopyridine
C20H19N3O2
CrystEngComm (2018) 20, 41 6377
a=7.549(5)Å b=8.736(6)Å c=13.095(8)Å
α=100.617(10)° β=99.729(9)° γ=93.918(9)°
Co-crystal of naproxen and 4,4'-azopyridine
C38H36N4O6
CrystEngComm (2018) 20, 41 6377
a=15.483(7)Å b=5.745(2)Å c=19.668(8)Å
α=90° β=110.025(8)° γ=90°
C18H8Br2F4N2
C18H8Br2F4N2
CrystEngComm (2018) 20, 45 7232
a=15.0550(7)Å b=5.2838(2)Å c=11.1874(5)Å
α=90° β=111.335(3)° γ=90°
C18H8Br2F4N2
C18H8Br2F4N2
CrystEngComm (2018) 20, 45 7232
a=15.0878(5)Å b=5.2804(2)Å c=11.2408(4)Å
α=90° β=111.346(2)° γ=90°
C18H8Br2F4N2
C18H8Br2F4N2
CrystEngComm (2018) 20, 45 7232
a=15.0775(9)Å b=5.2848(3)Å c=11.2151(7)Å
α=90° β=111.405(4)° γ=90°
C18H8Br2F4N2
C18H8Br2F4N2
CrystEngComm (2018) 20, 45 7232
a=15.1283(5)Å b=5.27450(10)Å c=11.2948(4)Å
α=90° β=111.348(2)° γ=90°
C18H8F4I2N2
C18H8F4I2N2
CrystEngComm (2018) 20, 45 7232
a=15.6409(8)Å b=5.2384(3)Å c=11.0229(5)Å
α=90° β=90° γ=90°
C18H8F4I2N2
C18H8F4I2N2
CrystEngComm (2018) 20, 45 7232
a=15.6537(5)Å b=5.2381(2)Å c=11.0524(3)Å
α=90° β=90° γ=90°
C18H8F4I2N2
C18H8F4I2N2
CrystEngComm (2018) 20, 45 7232
a=15.6966(9)Å b=5.2398(3)Å c=11.1314(6)Å
α=90° β=90° γ=90°
C18H10Br4N2
C18H10Br4N2
CrystEngComm (2018) 20, 45 7232
a=3.9366(3)Å b=13.2445(10)Å c=18.2177(16)Å
α=72.763(2)° β=85.794(2)° γ=83.955(2)°
C18H10Br4N2
C18H10Br4N2
CrystEngComm (2018) 20, 45 7232
a=3.9272(3)Å b=13.2313(11)Å c=18.2212(16)Å
α=72.682(2)° β=85.789(2)° γ=83.900(2)°
C18H10Br4N2
C18H10Br4N2
CrystEngComm (2018) 20, 45 7232
a=3.9684(4)Å b=13.2770(14)Å c=18.217(2)Å
α=73.014(3)° β=85.807(3)° γ=84.125(3)°
C18H10Br4N2
C18H10Br4N2
CrystEngComm (2018) 20, 45 7232
a=3.9578(3)Å b=13.2665(11)Å c=18.2186(18)Å
α=72.926(3)° β=85.798(3)° γ=84.065(2)°
C18H8F4I2N2
C18H8F4I2N2
CrystEngComm (2018) 20, 45 7232
a=15.6860(7)Å b=5.2395(2)Å c=11.1083(5)Å
α=90° β=90° γ=90°
C18H8F4I2N2
C18H8F4I2N2
CrystEngComm (2018) 20, 45 7232
a=15.6785(6)Å b=5.2396(2)Å c=11.0860(4)Å
α=90° β=90° γ=90°
C18H10Br4N2
C18H10Br4N2
CrystEngComm (2018) 20, 45 7232
a=3.9472(3)Å b=13.2528(10)Å c=18.2138(15)Å
α=72.838(2)° β=85.776(2)° γ=83.982(2)°
Co-crystal of mefenamic acid and 1,2-Bis(4-pyridyl)ethane
C21H21N2O2
CrystEngComm (2018) 20, 41 6377
a=7.450(7)Å b=7.835(7)Å c=16.895(16)Å
α=94.30(3)° β=93.160(17)° γ=117.89(2)°
Co-crystal of naproxen and 1,3-Bis(4-pyridyl)propane
C41H42N2O6
CrystEngComm (2018) 20, 41 6377
a=35.567(8)Å b=5.7333(15)Å c=33.199(8)Å
α=90° β=91.732(4)° γ=90°
C18H8Br2F4N2
C18H8Br2F4N2
CrystEngComm (2018) 20, 45 7232
a=15.1069(5)Å b=5.2772(2)Å c=11.2674(4)Å
α=90° β=111.344(2)° γ=90°
C6H4I2O2,C10H8N4
C6H4I2O2,C10H8N4
CrystEngComm (2016) 18, 43 8354
a=9.2387(9)Å b=10.4970(10)Å c=10.8284(11)Å
α=88.215(5)° β=69.551(5)° γ=64.302(5)°
C6H4Cl2O2,C10H8N4
C6H4Cl2O2,C10H8N4
CrystEngComm (2016) 18, 43 8354
a=8.9957(11)Å b=10.0831(13)Å c=10.4133(14)Å
α=89.154(5)° β=71.747(5)° γ=64.264(5)°
C6H4Cl2O2,C10H8N4
C6H4Cl2O2,C10H8N4
CrystEngComm (2016) 18, 43 8354
a=9.0188(9)Å b=10.1722(10)Å c=10.4719(10)Å
α=88.254(5)° β=71.579(5)° γ=64.025(5)°
C6H4Br2O2,C10H8N4
C6H4Br2O2,C10H8N4
CrystEngComm (2016) 18, 43 8354
a=9.0278(9)Å b=10.2654(10)Å c=10.6009(11)Å
α=75.203(5)° β=70.936(5)° γ=64.122(5)°
C6H4Br2O2,C10H8N4
C6H4Br2O2,C10H8N4
CrystEngComm (2016) 18, 43 8354
a=9.0497(9)Å b=10.3158(10)Å c=10.6690(11)Å
α=76.068(5)° β=70.779(5)° γ=64.511(5)°
C6H4I2O2,C10H8N4
C6H4I2O2,C10H8N4
CrystEngComm (2016) 18, 43 8354
a=9.2547(9)Å b=10.6163(11)Å c=10.8929(11)Å
α=74.976(5)° β=69.459(5)° γ=64.157(5)°
C10H8N4
C10H8N4
CrystEngComm (2016) 18, 43 8354
a=3.7762(4)Å b=5.8688(7)Å c=10.3157(12)Å
α=90.165(5)° β=95.411(5)° γ=99.256(5)°
C10H8N4
C10H8N4
CrystEngComm (2016) 18, 43 8354
a=3.8373(6)Å b=5.9282(7)Å c=10.3247(14)Å
α=90.671(7)° β=95.227(8)° γ=100.693(8)°
BPTE Succinic Acid
2(C11H9NS),C4H6O4
CrystEngComm (2014) 16, 26 5762
a=9.2826(10)Å b=19.692(2)Å c=13.6649(15)Å
α=90.00° β=108.704(5)° γ=90.00°
4p3tc
C22H18N2S2
CrystEngComm (2014) 16, 26 5762
a=11.6886(12)Å b=15.1755(15)Å c=12.1662(12)Å
α=90.00° β=117.334(5)° γ=90.00°
BPTE Adipic Acid
C11H9NS,C6H10O4
CrystEngComm (2014) 16, 26 5762
a=5.6534(6)Å b=8.1587(8)Å c=18.996(2)Å
α=83.851(5)° β=83.879(5)° γ=74.142(5)°
BPTE Glutaric Acid
2(C11H9NS),C5H8O4
CrystEngComm (2014) 16, 26 5762
a=15.9350(16)Å b=7.3782(7)Å c=21.823(3)Å
α=90.00° β=100.382(5)° γ=90.00°
C16.46H14.46N3.54O2
C16.46H14.46N3.54O2
Chemical Science (2020)
a=8.02672(12)Å b=9.79494(16)Å c=10.86753(18)Å
α=93.9195(13)° β=106.4603(14)° γ=113.7186(15)°
C18H14.6N2O2
C18H14.6N2O2
Chemical Science (2020)
a=8.18873(15)Å b=9.82362(13)Å c=10.94583(15)Å
α=92.3016(11)° β=108.0971(14)° γ=114.5370(15)°
4PAzP.4,6-diCl res 250
C6H4Cl2O2,2(C11H9N3)
Chem. Sci. (2015) 6, 8 4717
a=15.6347(16)Å b=15.9890(16)Å c=10.6460(11)Å
α=90.00° β=95.252(5)° γ=90.00°
4PAzP.4,6-diI res 290
C6H4I2O2,2(C11H9N3)
Chem. Sci. (2015) 6, 8 4717
a=9.0480(9)Å b=12.5933(13)Å c=26.305(3)Å
α=83.815(5)° β=89.271(5)° γ=75.005(5)°
BPE.4,6-diBr res
C12H10N2,C6H4Br2O2
Journal of the American Chemical Society (2015) 137, 40 12768-12771
a=9.0075(10)Å b=10.3117(12)Å c=10.8542(12)Å
α=76.877(5)° β=71.402(5)° γ=65.744(5)°
BPE.4,6-diIodo res
C12H10N2,C6H4I2O2
Journal of the American Chemical Society (2015) 137, 40 12768-12771
a=9.2179(10)Å b=10.6179(12)Å c=11.0370(12)Å
α=75.671(5)° β=70.310(5)° γ=64.891(5)°
Tetrakis(trans-1-(4-pyridyl)-2-phenylethylene-N)-bis (trifluoromethanesulfonate-O)-di-silver(I)
C26H22N2,AgCF3O3S
Journal of the American Chemical Society (2014) 136, 19 6778-6781
a=22.794(3)Å b=12.8303(13)Å c=18.2081(19)Å
α=90.00° β=94.293(5)° γ=90.00°
Bis(mu2-3,4-diphenylcyclobutane-1,2-bis(4-pyridyl)- N,N')-bis(trifluoromethanesulfonate-O)-di-silver(I)
C54H44Ag2F6N4O6S2
Journal of the American Chemical Society (2014) 136, 19 6778-6781
a=21.768(4)Å b=13.498(3)Å c=17.570(4)Å
α=90.00° β=98.24(3)° γ=90.00°
C16H8Cl4I2N4
C16H8Cl4I2N4
New Journal of Chemistry (2019)
a=4.05852(19)Å b=10.8342(4)Å c=12.4194(4)Å
α=111.498(3)° β=92.143(3)° γ=94.631(3)°